The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease

2004104 citationsJournal Article

Authors

Good health and well-being

Published in: Brain Research

Volume 1019, Issue 1-2, pp. 246-254

Field-Weighted Citation Impact: 1.81